# Sabatolimab (<scp>MBG453</scp>) model‐informed drug development for dose selection in patients with myelodysplastic syndrome/acute myeloid leukemia and solid tumors

> Research article (CPT Pharmacometrics & Systems Pharmacology, 2023) · cited 20× · AI/ML

**Wikidata**: [openalex:W4367054559](https://www.wikidata.org/wiki/openalex:W4367054559)  
**Source**: https://4ort.xyz/entity/sabatolimab-scp-mbg453-scp-modelinformed-drug-development-for-dose-selection-in-patients-with-myelodysplastic-syndrome-a